Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Unknown 15Not yet recruiting 3Completed 2Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Acute Toxic Effects 1

Interventions

Cyclophosphamide 1492Cisplatin 1413Paclitaxel 1316Radiotherapy 1261Carboplatin 1249Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700Etoposide 678pembrolizumab 677Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × lobaplatin × Clear all
NCT03413436 2020-08-28

Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma

Henan Cancer Hospital

Phase 4 Completed
733 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT03188497 2018-04-10

Dose Escalation of Lobaplatin Concurrent With IMRT for the Treatment of NPC: A Phase I Clinical Trial

Fifth Affiliated Hospital, Sun Yat-Sen University

Phase 1 Completed
17 enrolled

Acute Toxic Effects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡